Search research articles
Contact Us
Filters
Showing results (51-60 of 98) with videos related to
Page
of 10
Sort By:
Journal of Patient Experience
|
June 16, 2023
Understanding the Challenges Faced by Esophageal and Gastroesophageal Junction Cancer Survivors
Erin McGillivray, Rishi Jain, Chethan Ramamurthy, et al.
Cancer Medicine
|
September 3, 2021
Leveraging patient-reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experience
Arjun Gupta, Omar Khalid, Cassadie Moravek, et al.
Journal of the American College of Cardiology
|
December 10, 2025
Diagnosis and Management of Cardiovascular Adverse Effects of Targeted Oncology Therapies: Bruton's Tyrosine Kinase, Immune Checkpoint, and Vascular Endothelial Growth Factor Inhibitors: 2025 ACC Concise Clinical Guidance: A Report of the American College of Cardiology Solution Set Oversight Committee
Sarju Ganatra, Ana Barac, Saro Armenian, et al.
Pancreas
|
March 12, 2016
Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma
Efrat Dotan, R Katherine Alpaugh, Karen Ruth, et al.
Clinical Colorectal Cancer
|
February 12, 2014
A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers
Crystal S Denlinger, Neal J Meropol, Tianyu Li, et al.
Annals of Surgical Oncology
|
August 21, 2010
Defining venous involvement in borderline resectable pancreatic cancer
Yun Shin Chun, Barton N Milestone, James C Watson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 2, 2026
Measuring Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer Centers
Taneal D Carter, Ashley Orr, Carrie Richardson-Slater, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2020
Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer
Efrat Dotan, Dana B Cardin, Heinz-Josef Lenz, et al.
The Oncologist
|
March 6, 2019
First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer
Aiwu Ruth He, Roger B Cohen, Crystal S Denlinger, et al.
Cancer Chemotherapy and Pharmacology
|
May 6, 2009
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors
Crystal S Denlinger, Rebecca Blanchard, Lu Xu, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 98) with videos related to
Sort By:
Page
of 10
Journal of Patient Experience
|
June 16, 2023
Understanding the Challenges Faced by Esophageal and Gastroesophageal Junction Cancer Survivors
Erin McGillivray, Rishi Jain, Chethan Ramamurthy, et al.
Cancer Medicine
|
September 3, 2021
Leveraging patient-reported outcomes (PROs) in patients with pancreatic cancer: The Pancreatic Cancer Action Network (PanCAN) online patient registry experience
Arjun Gupta, Omar Khalid, Cassadie Moravek, et al.
Journal of the American College of Cardiology
|
December 10, 2025
Diagnosis and Management of Cardiovascular Adverse Effects of Targeted Oncology Therapies: Bruton's Tyrosine Kinase, Immune Checkpoint, and Vascular Endothelial Growth Factor Inhibitors: 2025 ACC Concise Clinical Guidance: A Report of the American College of Cardiology Solution Set Oversight Committee
Sarju Ganatra, Ana Barac, Saro Armenian, et al.
Pancreas
|
March 12, 2016
Prognostic Significance of MUC-1 in Circulating Tumor Cells in Patients With Metastatic Pancreatic Adenocarcinoma
Efrat Dotan, R Katherine Alpaugh, Karen Ruth, et al.
Clinical Colorectal Cancer
|
February 12, 2014
A phase II trial of the proteasome inhibitor bortezomib in patients with advanced biliary tract cancers
Crystal S Denlinger, Neal J Meropol, Tianyu Li, et al.
Annals of Surgical Oncology
|
August 21, 2010
Defining venous involvement in borderline resectable pancreatic cancer
Yun Shin Chun, Barton N Milestone, James C Watson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
July 2, 2026
Measuring Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer Centers
Taneal D Carter, Ashley Orr, Carrie Richardson-Slater, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 23, 2020
Phase Ib Study of Wnt Inhibitor Ipafricept with Gemcitabine and nab-paclitaxel in Patients with Previously Untreated Stage IV Pancreatic Cancer
Efrat Dotan, Dana B Cardin, Heinz-Josef Lenz, et al.
The Oncologist
|
March 6, 2019
First-in-Human Phase I Study of Merestinib, an Oral Multikinase Inhibitor, in Patients with Advanced Cancer
Aiwu Ruth He, Roger B Cohen, Crystal S Denlinger, et al.
Cancer Chemotherapy and Pharmacology
|
May 6, 2009
Pharmacokinetic analysis of irinotecan plus bevacizumab in patients with advanced solid tumors
Crystal S Denlinger, Rebecca Blanchard, Lu Xu, et al.
Page
of 10